When you enter multiple keywords separated by space, your search will contain results that match any of the keywords (OR search).
  • 14 Hits
  • Search Condition : Filter (MeSH = Cryptococcus neoformans / drug effects*)
Species Resource
Pathogenic microorganisms IFM 5854 , IFM 5855 , IFM 5856 , IFM 5857 Serotyping of Cryptococcus neoformans strains isolated from clinical specimens in Thailand and their susceptibility to various antifungal agents.
Pathogenic microorganisms IFM 49144 Deficit in oxygen causes G(2) budding and unbudded G(2) arrest in Cryptococcus neoformans.
Pathogenic microorganisms IFM 48213 , IFM 48214 , IFM 48215 , IFM 48216 , IFM 48217 , IFM 48218 , IFM 48219 , IFM 48220 , IFM 48221 , IFM 48222 , ... Antifungal susceptibilities, varieties, and electrophoretic karyotypes of clinical isolates of Cryptococcus neoformans from Brazil, Chile, and Venezuela.
Pathogenic microorganisms IFM 46541 , IFM 46543 , IFM 46545 Damage to yeast cells of Cryptococcus neoformans by voriconazole and fluconazole: a culture and microscopic study.
Pathogenic microorganisms C. neoformans? A new hexose transporter from Cryptococcus neoformans: molecular cloning and structural and functional characterization.
General Microbes JCM 1542 The antibiotic and membrane-damaging activities of cellobiose lipids and sophorose lipids.
Pathogenic microorganisms IFM 5817 , IFM 5880 , IFM 5882 , IFM 40215 , IFM 40216 , IFM 41362 , IFM 46089 , IFM 46139 , IFM 46501 , IFM 46660 , ... In-vitro antifungal activities of sulfa drugs against clinical isolates of Aspergillus and Cryptococcus species.
Pathogenic microorganisms Evaluation of antifungal combination against Cryptococcus spp.
Pathogenic microorganisms ? Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans.
Pathogenic microorganisms IFM 46895 , IFM 49895 In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Silkworms Quantitative evaluation of cryptococcal pathogenesis and antifungal drugs using a silkworm infection model with Cryptococcus neoformans.
Pathogenic microorganisms IFM 5844 , IFM 5845 , IFM 5860 , IFM 40009 , IFM 40022 , IFM 40038 , IFM 40078 , IFM 40190 , IFM 45940 , IFM 46816 , ... Characterisation of the anticryptococcal effect of the FC-1 toxin produced by Filobasidium capsuligenum.
General Microbes JCM2466 In vitro and in vivo antifungal activities of T-2307, a novel arylamidine.
Pathogenic microorganisms IFM 49150 Secondary cell wall formation in Cryptococcus neoformans as a rescue mechanism against acid-induced autolysis.